Company Encyclopedia
View More
name
Dongbao Bio-Tech
300239.SZ
Baotou Dongbao Bio-Tech Co.,Ltd engages in the research and development, production, and sale of gelatin, collagen, and additional products in the People’s Republic of China and internationally. It offers gelatin for jelly, confection, yogurt, plasma substitute, tablets, softgel, photographic paper, and hard capsules; plasma gelatin substitute, hollow capsule, double protein dietary fiber, cosmetics, and other products; agglomerated collagen peptide; hydrolyzed collagen power and granule; collagen peptide power and granule; hydrolyzed fish collagen; collagen jars; and fish collagen peptide powder, as well as food additive and pharmaceutical gelatin. The company also engages in research and development, production, and sale of bio-organic fertilizers, including industrial and feed grade calcium hydrogen phosphate; inorganic and organic microorganisms fertilizers; nitrogen fertilizers; calcium amino acid fertilizer; bone-derived biological calcium fertilizer; and biological and refined organic fertilizer. In addition, it is involved in the research and development, production, and sale of empty capsules.
1.910 T
300239.SZMarket value -Rank by Market Cap -/-

Financial Score

05/12/2025 Update
C
Specialty ChemicalsIndustry
Industry Ranking118/154
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreC
    • ROE3.97%C
    • Profit Margin8.69%B
    • Gross Margin24.60%C
  • Growth ScoreD
    • Revenue YoY-10.12%D
    • Net Profit YoY-25.02%D
    • Total Assets YoY-6.39%D
    • Net Assets YoY-0.20%C
  • Cash ScoreC
    • Cash Flow Margin1151.17%B
    • OCF YoY-10.12%D
  • Operating ScoreD
    • Turnover0.3D
  • Debt ScoreB
    • Gearing Ratio32.50%B

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    The concept of artificial meat is active at the beginning of trading, SHUANGTA FOOD hits the limit up

    In the morning session, the plant-based meat concept was active, with SHUANGTA FOOD hitting the daily limit, and Solbar, Dongbao Bio-Tech, HAOXIANGNI, and Huabao Limited following suit

    Zhitong·
    SZ
    300239
    +0.53%
    SZ
    002582
    +2.00%
    SZ
    300741
    +6.00%
    Zhitong·
    SZ
    300239
    +0.53%
    SZ
    002582
    +2.00%
    SZ
    300741
    +6.00%

    Dongbao Bio-Tech: "Dongbao Convertible Bonds" are expected to trigger conditions for a downward adjustment of the conversion price

    Dongbao Bio-Tech announced that it is expected to trigger the condition for the downward adjustment of the conversion price of the "Dongbao Convertible Bond." From September 17 to September 30, 2025, the closing price of the company's stock has been below RMB 6.63 per share for 90% of the ten trading days. The total amount of this convertible bond issuance is RMB 455 million, listed on August 18, 2023, with a conversion period from February 5, 2024, to July 30, 2029. If the adjustment condition is triggered, the board of directors will decide whether to propose an adjustment plan and submit it for shareholder meeting review, reminding investors to pay attention to risks

    Zhitong·
    SZ
    300239
    +0.53%
    Zhitong·
    SZ
    300239
    +0.53%

    Dongbao Bio-Tech released its performance for the first half of the year, with a net profit attributable to the parent company of 36.9673 million yuan, a decrease of 28.00%

    Dongbao Bio-Tech released its semi-annual report for 2025, with operating revenue of 369 million yuan, a year-on-year decrease of 16.93%; net profit attributable to the parent company was 36.9673 million yuan, a year-on-year decline of 28.00%; net profit excluding non-recurring gains and losses was 33.4351 million yuan, a year-on-year decrease of 27.41%; basic earnings per share were 0.0629 yuan

    Zhitong·
    SZ
    300239
    +0.53%
    Zhitong·
    SZ
    300239
    +0.53%

    Dongbao Bio-Tech: "Beiyou Mian Brand Collagen Protein Vitamin C Powder" product has obtained the domestic health food registration certificate

    Dongbao Bio-Tech announced that the company's "Beiyou Mianpai Collagen Protein Vitamin C Powder" product has recently completed the registration work for domestic health food and has obtained the domestic health food registration certificate issued by the State Administration for Market Regulation. This product has health functions that help enhance immunity, with registration number Guo Shi Jian Zhu G20250138, valid until April 29, 2030

    Zhitong·
    SZ
    300239
    +0.53%
    Zhitong·
    SZ
    300239
    +0.53%

    Dongbao Bio-Tech released its 2024 annual performance, with a net profit attributable to the parent company of 85.9827 million yuan, a year-on-year decrease of 28.28%

    Dongbao Bio-Tech released its 2024 annual report, with operating revenue of 885 million yuan, a year-on-year decrease of 9.19%; net profit attributable to shareholders was 85.9827 million yuan, a year-on-year decrease of 28.28%; net profit excluding non-recurring gains and losses was 79.0893 million yuan, a year-on-year decrease of 28.17%; basic earnings per share were 0.1448 yuan/share. The company plans to distribute a cash dividend of 0.25 yuan (tax included) for every 10 shares

    Zhitong·
    SZ
    300239
    +0.53%
    Zhitong·
    SZ
    300239
    +0.53%
    © 2025 Longbridge｜Disclaimer